Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
745
-919
-55% -$315K 0.24% 135
2026
Q1
$586K Buy
+1,664
New +$593K 0.46% 60

Other funds holding AMGN

Van Diest Capital's AMGN Position: Q2 2026 in Review

Van Diest Capital reduced its Amgen (AMGN) stake by 55% in Q2 2026, selling an estimated $315K and leaving 745 shares worth $270K. The position accounts for 0.24% of the portfolio, ranked #135.

Van Diest Capital first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $586K in Q1 2026. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Van Diest Capital held 745 shares of Amgen worth $270K as of Q2 2026.
  • Van Diest Capital sold 919 Amgen shares in Q2 2026, an estimated $315K.
  • Amgen made up 0.24% of Van Diest Capital's portfolio in Q2 2026, its #135 holding.
  • Van Diest Capital first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • Van Diest Capital's Amgen position peaked at $586K in Q1 2026.
  • 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Van Diest Capital's 13F filing for Q2 2026, filed 4 Aug 2026.